ID SC6A1_MOUSE Reviewed; 599 AA. AC P31648; DT 01-JUL-1993, integrated into UniProtKB/Swiss-Prot. DT 10-MAY-2004, sequence version 2. DT 27-MAR-2024, entry version 178. DE RecName: Full=Sodium- and chloride-dependent GABA transporter 1; DE Short=GAT-1; DE AltName: Full=Solute carrier family 6 member 1; GN Name=Slc6a1; Synonyms=Gabt1, Gat-1, Gat1; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]. RX PubMed=1631167; DOI=10.1073/pnas.89.14.6639; RA Liu Q.-R., Mandiyan S., Nelson H., Nelson N.; RT "A family of genes encoding neurotransmitter transporters."; RL Proc. Natl. Acad. Sci. U.S.A. 89:6639-6643(1992). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6J; TISSUE=Cerebellum, Eye, and Head; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [3] RP FUNCTION, TRANSPORTER ACTIVITY, AND ACTIVITY REGULATION. RX PubMed=8420981; DOI=10.1016/s0021-9258(18)53968-5; RA Liu Q.-R., Lopez-Coecuera B., Mandiyan S., Nelson H., Nelson N.; RT "Molecular characterization of four pharmacologically distinct gamma- RT aminobutyric acid transporters in mouse brain."; RL J. Biol. Chem. 268:2106-2112(1993). RN [4] RP FUNCTION, TRANSPORTER ACTIVITY, INTERACTION WITH PALS1, TISSUE SPECIFICITY, RP AND SUBCELLULAR LOCATION. RX PubMed=15234345; DOI=10.1016/j.mcn.2004.03.006; RA McHugh E.M., Zhu W., Milgram S., Mager S.; RT "The GABA transporter GAT1 and the MAGUK protein Pals1: interaction, uptake RT modulation, and coexpression in the brain."; RL Mol. Cell. Neurosci. 26:406-417(2004). RN [5] RP FUNCTION, TRANSPORTER ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND ACTIVITY RP REGULATION. RX PubMed=16150932; DOI=10.1124/mol.105.013870; RA Krause S., Schwarz W.; RT "Identification and selective inhibition of the channel mode of the RT neuronal GABA transporter 1."; RL Mol. Pharmacol. 68:1728-1735(2005). RN [6] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18 AND SER-591, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [7] RP FUNCTION, AND TRANSPORTER ACTIVITY. RX PubMed=30270321; DOI=10.1248/bpb.b18-00168; RA Nishimura T., Higuchi K., Yoshida Y., Sugita-Fujisawa Y., Kojima K., RA Sugimoto M., Santo M., Tomi M., Nakashima E.; RT "Hypotaurine Is a Substrate of GABA Transporter Family Members GAT2/Slc6a13 RT and TAUT/Slc6a6."; RL Biol. Pharm. Bull. 41:1523-1529(2018). CC -!- FUNCTION: Mediates transport of gamma-aminobutyric acid (GABA) together CC with sodium and chloride and is responsible for the reuptake of GABA CC from the synapse (PubMed:15234345, PubMed:16150932, PubMed:8420981, CC PubMed:30270321). The translocation of GABA, however, may also occur in CC the reverse direction leading to the release of GABA (By similarity). CC The direction and magnitude of GABA transport is a consequence of the CC prevailing thermodynamic conditions, determined by membrane potential CC and the intracellular and extracellular concentrations of Na(+), Cl(-) CC and GABA (By similarity). Can also mediate sodium- and chloride- CC dependent transport of hypotaurine but to a much lower extent as CC compared to GABA (PubMed:30270321). {ECO:0000250|UniProtKB:P23978, CC ECO:0000269|PubMed:15234345, ECO:0000269|PubMed:16150932, CC ECO:0000269|PubMed:30270321, ECO:0000269|PubMed:8420981}. CC -!- CATALYTIC ACTIVITY: CC Reaction=4-aminobutanoate(out) + chloride(out) + 2 Na(+)(out) = 4- CC aminobutanoate(in) + chloride(in) + 2 Na(+)(in); CC Xref=Rhea:RHEA:70687, ChEBI:CHEBI:17996, ChEBI:CHEBI:29101, CC ChEBI:CHEBI:59888; Evidence={ECO:0000269|PubMed:15234345, CC ECO:0000269|PubMed:16150932, ECO:0000269|PubMed:30270321, CC ECO:0000269|PubMed:8420981}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70688; CC Evidence={ECO:0000305|PubMed:15234345}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:70689; CC Evidence={ECO:0000250|UniProtKB:P23978}; CC -!- CATALYTIC ACTIVITY: CC Reaction=chloride(out) + hypotaurine(out) + 2 Na(+)(out) = chloride(in) CC + hypotaurine(in) + 2 Na(+)(in); Xref=Rhea:RHEA:71243, CC ChEBI:CHEBI:17996, ChEBI:CHEBI:29101, ChEBI:CHEBI:57853; CC Evidence={ECO:0000269|PubMed:30270321}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:71244; CC Evidence={ECO:0000305|PubMed:30270321}; CC -!- ACTIVITY REGULATION: Inhibited by N-[4,4-Diphenyl-3-butenyl]-nipecotic CC acid (SKF-89976-A), L-2,4-diamino-n-butyric acid, guvacine and CC nipecotic acid. {ECO:0000269|PubMed:16150932, CC ECO:0000269|PubMed:8420981}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=62 uM for GABA {ECO:0000269|PubMed:16150932}; CC -!- SUBUNIT: Interacts (via PDZ domain-binding motif) with PALS1; CC interaction increases SLC6A1-mediated GABA uptake. CC {ECO:0000269|PubMed:15234345}. CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P23978}; CC Multi-pass membrane protein {ECO:0000255}. Presynapse CC {ECO:0000269|PubMed:15234345}. Note=Localized at the presynaptic CC terminals of interneurons. {ECO:0000269|PubMed:15234345}. CC -!- TISSUE SPECIFICITY: Brain. Expressed in the dentate gyrus of CC hippocampus, striatum and cerebellum (at protein level). CC {ECO:0000269|PubMed:15234345}. CC -!- MISCELLANEOUS: This protein is the target of psychomotor stimulants CC such as amphetamines or cocaine. CC -!- SIMILARITY: Belongs to the sodium:neurotransmitter symporter (SNF) CC (TC 2.A.22) family. SLC6A1 subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M92377; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; M92378; -; NOT_ANNOTATED_CDS; mRNA. DR EMBL; AK042956; BAC31418.1; -; mRNA. DR EMBL; AK052971; BAC35226.1; -; mRNA. DR EMBL; AK053883; BAC35574.1; -; mRNA. DR CCDS; CCDS20434.1; -. DR PIR; F46027; F46027. DR RefSeq; NP_848818.1; NM_178703.4. DR AlphaFoldDB; P31648; -. DR SMR; P31648; -. DR BioGRID; 231239; 85. DR IntAct; P31648; 1. DR MINT; P31648; -. DR STRING; 10090.ENSMUSP00000032454; -. DR BindingDB; P31648; -. DR ChEMBL; CHEMBL5445; -. DR DrugCentral; P31648; -. DR GuidetoPHARMACOLOGY; 929; -. DR GlyCosmos; P31648; 3 sites, No reported glycans. DR GlyGen; P31648; 4 sites, 1 O-linked glycan (1 site). DR iPTMnet; P31648; -. DR PhosphoSitePlus; P31648; -. DR SwissPalm; P31648; -. DR MaxQB; P31648; -. DR PaxDb; 10090-ENSMUSP00000032454; -. DR PeptideAtlas; P31648; -. DR ProteomicsDB; 256737; -. DR Antibodypedia; 1391; 315 antibodies from 33 providers. DR DNASU; 232333; -. DR Ensembl; ENSMUST00000032454.8; ENSMUSP00000032454.6; ENSMUSG00000030310.12. DR GeneID; 232333; -. DR KEGG; mmu:232333; -. DR UCSC; uc009dhu.2; mouse. DR AGR; MGI:95627; -. DR CTD; 6529; -. DR MGI; MGI:95627; Slc6a1. DR VEuPathDB; HostDB:ENSMUSG00000030310; -. DR eggNOG; KOG3660; Eukaryota. DR GeneTree; ENSGT00940000156027; -. DR HOGENOM; CLU_006855_9_5_1; -. DR InParanoid; P31648; -. DR OMA; TIWFVSR; -. DR OrthoDB; 3084493at2759; -. DR PhylomeDB; P31648; -. DR TreeFam; TF343812; -. DR Reactome; R-MMU-442660; Na+/Cl- dependent neurotransmitter transporters. DR Reactome; R-MMU-888593; Reuptake of GABA. DR BioGRID-ORCS; 232333; 4 hits in 79 CRISPR screens. DR PRO; PR:P31648; -. DR Proteomes; UP000000589; Chromosome 6. DR RNAct; P31648; Protein. DR Bgee; ENSMUSG00000030310; Expressed in cerebellum lobe and 107 other cell types or tissues. DR ExpressionAtlas; P31648; baseline and differential. DR GO; GO:0030424; C:axon; IDA:ARUK-UCL. DR GO; GO:0009986; C:cell surface; ISO:MGI. DR GO; GO:0098982; C:GABA-ergic synapse; IDA:SynGO. DR GO; GO:0043025; C:neuronal cell body; IDA:ARUK-UCL. DR GO; GO:0005886; C:plasma membrane; IDA:MGI. DR GO; GO:0045211; C:postsynaptic membrane; ISO:MGI. DR GO; GO:0042734; C:presynaptic membrane; ISO:MGI. DR GO; GO:0005283; F:amino acid:sodium symporter activity; IDA:UniProtKB. DR GO; GO:0015185; F:gamma-aminobutyric acid transmembrane transporter activity; IMP:ARUK-UCL. DR GO; GO:0005332; F:gamma-aminobutyric acid:sodium:chloride symporter activity; IDA:UniProtKB. DR GO; GO:0042802; F:identical protein binding; ISO:MGI. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0015378; F:sodium:chloride symporter activity; ISO:MGI. DR GO; GO:0008306; P:associative learning; IMP:ARUK-UCL. DR GO; GO:1902476; P:chloride transmembrane transport; ISO:MGI. DR GO; GO:0051939; P:gamma-aminobutyric acid import; IMP:ARUK-UCL. DR GO; GO:0098658; P:inorganic anion import across plasma membrane; ISO:MGI. DR GO; GO:0007612; P:learning; ISO:MGI. DR GO; GO:0007613; P:memory; IMP:ARUK-UCL. DR GO; GO:0032229; P:negative regulation of synaptic transmission, GABAergic; ISO:MGI. DR GO; GO:0098810; P:neurotransmitter reuptake; IDA:SynGO. DR GO; GO:0014054; P:positive regulation of gamma-aminobutyric acid secretion; ISO:MGI. DR GO; GO:0010035; P:response to inorganic substance; ISO:MGI. DR GO; GO:0010033; P:response to organic substance; ISO:MGI. DR GO; GO:0014074; P:response to purine-containing compound; ISO:MGI. DR GO; GO:0009636; P:response to toxic substance; ISO:MGI. DR GO; GO:0098719; P:sodium ion import across plasma membrane; ISO:MGI. DR GO; GO:0035725; P:sodium ion transmembrane transport; IBA:GO_Central. DR GO; GO:0050808; P:synapse organization; IMP:ARUK-UCL. DR CDD; cd11506; SLC6sbd_GAT1; 1. DR InterPro; IPR000175; Na/ntran_symport. DR InterPro; IPR002980; Na/ntran_symport_GABA_GAT1. DR InterPro; IPR037272; SNS_sf. DR NCBIfam; NF037979; Na_transp; 1. DR PANTHER; PTHR11616:SF138; SODIUM- AND CHLORIDE-DEPENDENT GABA TRANSPORTER 1; 1. DR PANTHER; PTHR11616; SODIUM/CHLORIDE DEPENDENT TRANSPORTER; 1. DR Pfam; PF00209; SNF; 1. DR PRINTS; PR01195; GAT1TRNSPORT. DR PRINTS; PR00176; NANEUSMPORT. DR SUPFAM; SSF161070; SNF-like; 1. DR PROSITE; PS00610; NA_NEUROTRAN_SYMP_1; 1. DR PROSITE; PS00754; NA_NEUROTRAN_SYMP_2; 1. DR PROSITE; PS50267; NA_NEUROTRAN_SYMP_3; 1. DR Genevisible; P31648; MM. PE 1: Evidence at protein level; KW Cell membrane; Cell projection; Disulfide bond; Glycoprotein; Membrane; KW Metal-binding; Neurotransmitter transport; Phosphoprotein; KW Reference proteome; Sodium; Symport; Synapse; Transmembrane; KW Transmembrane helix; Transport. FT CHAIN 1..599 FT /note="Sodium- and chloride-dependent GABA transporter 1" FT /id="PRO_0000214744" FT TOPO_DOM 1..52 FT /note="Cytoplasmic" FT /evidence="ECO:0000250|UniProtKB:P23978" FT TRANSMEM 53..73 FT /note="Helical; Name=1" FT /evidence="ECO:0000255" FT TOPO_DOM 74..80 FT /note="Extracellular" FT /evidence="ECO:0000250|UniProtKB:P23978" FT TRANSMEM 81..100 FT /note="Helical; Name=2" FT /evidence="ECO:0000255" FT TOPO_DOM 101..123 FT /note="Cytoplasmic" FT /evidence="ECO:0000250|UniProtKB:P23978" FT TRANSMEM 124..144 FT /note="Helical; Name=3" FT /evidence="ECO:0000255" FT TOPO_DOM 145..211 FT /note="Extracellular" FT /evidence="ECO:0000250|UniProtKB:P23978" FT TRANSMEM 212..230 FT /note="Helical; Name=4" FT /evidence="ECO:0000255" FT TOPO_DOM 231..238 FT /note="Cytoplasmic" FT /evidence="ECO:0000250|UniProtKB:P23978" FT TRANSMEM 239..256 FT /note="Helical; Name=5" FT /evidence="ECO:0000255" FT TOPO_DOM 257..291 FT /note="Extracellular" FT /evidence="ECO:0000250|UniProtKB:P23978" FT TRANSMEM 292..309 FT /note="Helical; Name=6" FT /evidence="ECO:0000255" FT TOPO_DOM 310..320 FT /note="Cytoplasmic" FT /evidence="ECO:0000250|UniProtKB:P23978" FT TRANSMEM 321..342 FT /note="Helical; Name=7" FT /evidence="ECO:0000255" FT TOPO_DOM 343..374 FT /note="Extracellular" FT /evidence="ECO:0000250|UniProtKB:P23978" FT TRANSMEM 375..394 FT /note="Helical; Name=8" FT /evidence="ECO:0000255" FT TOPO_DOM 395..421 FT /note="Cytoplasmic" FT /evidence="ECO:0000250|UniProtKB:P23978" FT TRANSMEM 422..440 FT /note="Helical; Name=9" FT /evidence="ECO:0000255" FT TOPO_DOM 441..456 FT /note="Extracellular" FT /evidence="ECO:0000250|UniProtKB:P23978" FT TRANSMEM 457..477 FT /note="Helical; Name=10" FT /evidence="ECO:0000255" FT TOPO_DOM 478..497 FT /note="Cytoplasmic" FT /evidence="ECO:0000250|UniProtKB:P23978" FT TRANSMEM 498..517 FT /note="Helical; Name=11" FT /evidence="ECO:0000255" FT TOPO_DOM 518..535 FT /note="Extracellular" FT /evidence="ECO:0000250|UniProtKB:P23978" FT TRANSMEM 536..554 FT /note="Helical; Name=12" FT /evidence="ECO:0000255" FT TOPO_DOM 555..599 FT /note="Cytoplasmic" FT /evidence="ECO:0000250|UniProtKB:P23978" FT REGION 1..23 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 577..599 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 597..599 FT /note="PDZ-binding" FT COMPBIAS 1..19 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 59 FT /ligand="Na(+)" FT /ligand_id="ChEBI:CHEBI:29101" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:Q7K4Y6" FT BINDING 61 FT /ligand="Na(+)" FT /ligand_id="ChEBI:CHEBI:29101" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:Q7K4Y6" FT BINDING 62 FT /ligand="Na(+)" FT /ligand_id="ChEBI:CHEBI:29101" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:Q7K4Y6" FT BINDING 66 FT /ligand="Na(+)" FT /ligand_id="ChEBI:CHEBI:29101" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:Q7K4Y6" FT BINDING 295 FT /ligand="Na(+)" FT /ligand_id="ChEBI:CHEBI:29101" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:Q7K4Y6" FT BINDING 327 FT /ligand="Na(+)" FT /ligand_id="ChEBI:CHEBI:29101" FT /ligand_label="2" FT /evidence="ECO:0000250|UniProtKB:Q7K4Y6" FT BINDING 392 FT /ligand="Na(+)" FT /ligand_id="ChEBI:CHEBI:29101" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:Q7K4Y6" FT BINDING 395 FT /ligand="Na(+)" FT /ligand_id="ChEBI:CHEBI:29101" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:Q7K4Y6" FT BINDING 396 FT /ligand="Na(+)" FT /ligand_id="ChEBI:CHEBI:29101" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:Q7K4Y6" FT MOD_RES 18 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 591 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT CARBOHYD 176 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 181 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 184 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 164..173 FT /evidence="ECO:0000250|UniProtKB:Q7K4Y6" FT CONFLICT 117..118 FT /note="KL -> NW (in Ref. 1; M92378)" FT /evidence="ECO:0000305" FT CONFLICT 126..127 FT /note="GL -> AV (in Ref. 1; M92378)" FT /evidence="ECO:0000305" FT CONFLICT 212..213 FT /note="WP -> C (in Ref. 1; M92378)" FT /evidence="ECO:0000305" FT CONFLICT 285..286 FT /note="WL -> IF (in Ref. 1; M92378)" FT /evidence="ECO:0000305" SQ SEQUENCE 599 AA; 67001 MW; 4FEF85092DC1D045 CRC64; MATDNSKVAD GQISTEVSEA PVASDKPKTL VVKVQKKAGD LPDRDTWKGR FDFLMSCVGY AIGLGNVWRF PYLCGKNGGG AFLIPYFLTL IFAGVPLFLL ECSLGQYTSI GGLGVWKLAP MFKGVGLAAA VLSFWLNIYY IVIISWAIYY LYNSFTTTLP WKQCDNPWNT DRCFSNYSLV NTTNMTSAVV EFWERNMHQM TDGLDKPGQI RWPLAITLAI AWVLVYFCIW KGVGWTGKVV YFSATYPYIM LIILFFRGVT LPGAKEGILF YITPNFRKLS DSEVWLDAAT QIFFSYGLGL GSLIALGSYN SFHNNVYRDS IIVCCINSCT SMFAGFVIFS IVGFMAHVTK RSIADVAASG PGLAFLAYPE AVTQLPISPL WAILFFSMLL MLGIDSQFCT VEGFITALVD EYPRLLRNRR ELFIAAVCIV SYLIGLSNIT QGGIYVFKLF DYYSASGMSL LFLVFFECVS ISWFYGVNRF YDNIQEMVGS RPCIWWKLCW SFFTPIIVAG VFLFSAVQMT PLTMGSYVFP KWGQGVGWLM ALSSMVLIPG YMAYMFLTLK GSLKQRLQVM IQPSEDIVRP ENGPEQPQAG SSASKEAYI //